Global Human Vaccination Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or 'wild' pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
LPI (LP Information)' newest research report, the “Human Vaccination Industry Forecast” looks at past sales and reviews total world Human Vaccination sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Vaccination sales for 2023 through 2029. With Human Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Vaccination industry.
This Insight Report provides a comprehensive analysis of the global Human Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Human Vaccination market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Vaccination and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Vaccination.
The global Human Vaccination market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Human Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Human Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Human Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Human Vaccination players cover GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS and Convac, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Vaccination market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Human Vaccination market?
What factors are driving Human Vaccination market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Vaccination market opportunities vary by end market size?
How does Human Vaccination break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or 'wild' pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
LPI (LP Information)' newest research report, the “Human Vaccination Industry Forecast” looks at past sales and reviews total world Human Vaccination sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Vaccination sales for 2023 through 2029. With Human Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Vaccination industry.
This Insight Report provides a comprehensive analysis of the global Human Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Human Vaccination market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Vaccination and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Vaccination.
The global Human Vaccination market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Human Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Human Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Human Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Human Vaccination players cover GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS and Convac, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Vaccination market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Inactivated Vaccine
- Live-attenuated Vaccine
- mRNA Vaccine
- Conjugate Vaccine
- Other
- Government Institution
- Private Sector
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- Merck
- Sanofi
- Sinovac
- Zhejiang Pukang
- Changchun Institute of Biological
- KM Biologics
- IMBCAMS
- Convac
- NCPC
- Bio Kangtai
- Dynavax
- Hissen
- KM Biologics
- LG Life Sciences
- Serum Institute
- Pfizer
What is the 10-year outlook for the global Human Vaccination market?
What factors are driving Human Vaccination market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Vaccination market opportunities vary by end market size?
How does Human Vaccination break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Vaccination Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Human Vaccination by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Human Vaccination by Country/Region, 2018, 2022 & 2029
2.2 Human Vaccination Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Live-attenuated Vaccine
2.2.3 mRNA Vaccine
2.2.4 Conjugate Vaccine
2.2.5 Other
2.3 Human Vaccination Sales by Type
2.3.1 Global Human Vaccination Sales Market Share by Type (2018-2023)
2.3.2 Global Human Vaccination Revenue and Market Share by Type (2018-2023)
2.3.3 Global Human Vaccination Sale Price by Type (2018-2023)
2.4 Human Vaccination Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.4.3 Other
2.5 Human Vaccination Sales by Application
2.5.1 Global Human Vaccination Sale Market Share by Application (2018-2023)
2.5.2 Global Human Vaccination Revenue and Market Share by Application (2018-2023)
2.5.3 Global Human Vaccination Sale Price by Application (2018-2023)
3 GLOBAL HUMAN VACCINATION BY COMPANY
3.1 Global Human Vaccination Breakdown Data by Company
3.1.1 Global Human Vaccination Annual Sales by Company (2018-2023)
3.1.2 Global Human Vaccination Sales Market Share by Company (2018-2023)
3.2 Global Human Vaccination Annual Revenue by Company (2018-2023)
3.2.1 Global Human Vaccination Revenue by Company (2018-2023)
3.2.2 Global Human Vaccination Revenue Market Share by Company (2018-2023)
3.3 Global Human Vaccination Sale Price by Company
3.4 Key Manufacturers Human Vaccination Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Vaccination Product Location Distribution
3.4.2 Players Human Vaccination Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HUMAN VACCINATION BY GEOGRAPHIC REGION
4.1 World Historic Human Vaccination Market Size by Geographic Region (2018-2023)
4.1.1 Global Human Vaccination Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Human Vaccination Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Human Vaccination Market Size by Country/Region (2018-2023)
4.2.1 Global Human Vaccination Annual Sales by Country/Region (2018-2023)
4.2.2 Global Human Vaccination Annual Revenue by Country/Region (2018-2023)
4.3 Americas Human Vaccination Sales Growth
4.4 APAC Human Vaccination Sales Growth
4.5 Europe Human Vaccination Sales Growth
4.6 Middle East & Africa Human Vaccination Sales Growth
5 AMERICAS
5.1 Americas Human Vaccination Sales by Country
5.1.1 Americas Human Vaccination Sales by Country (2018-2023)
5.1.2 Americas Human Vaccination Revenue by Country (2018-2023)
5.2 Americas Human Vaccination Sales by Type
5.3 Americas Human Vaccination Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Vaccination Sales by Region
6.1.1 APAC Human Vaccination Sales by Region (2018-2023)
6.1.2 APAC Human Vaccination Revenue by Region (2018-2023)
6.2 APAC Human Vaccination Sales by Type
6.3 APAC Human Vaccination Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Vaccination by Country
7.1.1 Europe Human Vaccination Sales by Country (2018-2023)
7.1.2 Europe Human Vaccination Revenue by Country (2018-2023)
7.2 Europe Human Vaccination Sales by Type
7.3 Europe Human Vaccination Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Vaccination by Country
8.1.1 Middle East & Africa Human Vaccination Sales by Country (2018-2023)
8.1.2 Middle East & Africa Human Vaccination Revenue by Country (2018-2023)
8.2 Middle East & Africa Human Vaccination Sales by Type
8.3 Middle East & Africa Human Vaccination Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Vaccination
10.3 Manufacturing Process Analysis of Human Vaccination
10.4 Industry Chain Structure of Human Vaccination
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Vaccination Distributors
11.3 Human Vaccination Customer
12 WORLD FORECAST REVIEW FOR HUMAN VACCINATION BY GEOGRAPHIC REGION
12.1 Global Human Vaccination Market Size Forecast by Region
12.1.1 Global Human Vaccination Forecast by Region (2024-2029)
12.1.2 Global Human Vaccination Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Vaccination Forecast by Type
12.7 Global Human Vaccination Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Human Vaccination Product Portfolios and Specifications
13.1.3 GSK Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Human Vaccination Product Portfolios and Specifications
13.2.3 Merck Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Human Vaccination Product Portfolios and Specifications
13.3.3 Sanofi Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Sinovac
13.4.1 Sinovac Company Information
13.4.2 Sinovac Human Vaccination Product Portfolios and Specifications
13.4.3 Sinovac Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sinovac Main Business Overview
13.4.5 Sinovac Latest Developments
13.5 Zhejiang Pukang
13.5.1 Zhejiang Pukang Company Information
13.5.2 Zhejiang Pukang Human Vaccination Product Portfolios and Specifications
13.5.3 Zhejiang Pukang Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Zhejiang Pukang Main Business Overview
13.5.5 Zhejiang Pukang Latest Developments
13.6 Changchun Institute of Biological
13.6.1 Changchun Institute of Biological Company Information
13.6.2 Changchun Institute of Biological Human Vaccination Product Portfolios and Specifications
13.6.3 Changchun Institute of Biological Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Changchun Institute of Biological Main Business Overview
13.6.5 Changchun Institute of Biological Latest Developments
13.7 KM Biologics
13.7.1 KM Biologics Company Information
13.7.2 KM Biologics Human Vaccination Product Portfolios and Specifications
13.7.3 KM Biologics Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 KM Biologics Main Business Overview
13.7.5 KM Biologics Latest Developments
13.8 IMBCAMS
13.8.1 IMBCAMS Company Information
13.8.2 IMBCAMS Human Vaccination Product Portfolios and Specifications
13.8.3 IMBCAMS Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 IMBCAMS Main Business Overview
13.8.5 IMBCAMS Latest Developments
13.9 Convac
13.9.1 Convac Company Information
13.9.2 Convac Human Vaccination Product Portfolios and Specifications
13.9.3 Convac Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Convac Main Business Overview
13.9.5 Convac Latest Developments
13.10 NCPC
13.10.1 NCPC Company Information
13.10.2 NCPC Human Vaccination Product Portfolios and Specifications
13.10.3 NCPC Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 NCPC Main Business Overview
13.10.5 NCPC Latest Developments
13.11 Bio Kangtai
13.11.1 Bio Kangtai Company Information
13.11.2 Bio Kangtai Human Vaccination Product Portfolios and Specifications
13.11.3 Bio Kangtai Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Bio Kangtai Main Business Overview
13.11.5 Bio Kangtai Latest Developments
13.12 Dynavax
13.12.1 Dynavax Company Information
13.12.2 Dynavax Human Vaccination Product Portfolios and Specifications
13.12.3 Dynavax Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Dynavax Main Business Overview
13.12.5 Dynavax Latest Developments
13.13 Hissen
13.13.1 Hissen Company Information
13.13.2 Hissen Human Vaccination Product Portfolios and Specifications
13.13.3 Hissen Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Hissen Main Business Overview
13.13.5 Hissen Latest Developments
13.14 KM Biologics
13.14.1 KM Biologics Company Information
13.14.2 KM Biologics Human Vaccination Product Portfolios and Specifications
13.14.3 KM Biologics Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 KM Biologics Main Business Overview
13.14.5 KM Biologics Latest Developments
13.15 LG Life Sciences
13.15.1 LG Life Sciences Company Information
13.15.2 LG Life Sciences Human Vaccination Product Portfolios and Specifications
13.15.3 LG Life Sciences Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 LG Life Sciences Main Business Overview
13.15.5 LG Life Sciences Latest Developments
13.16 Serum Institute
13.16.1 Serum Institute Company Information
13.16.2 Serum Institute Human Vaccination Product Portfolios and Specifications
13.16.3 Serum Institute Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Serum Institute Main Business Overview
13.16.5 Serum Institute Latest Developments
13.17 Pfizer
13.17.1 Pfizer Company Information
13.17.2 Pfizer Human Vaccination Product Portfolios and Specifications
13.17.3 Pfizer Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Pfizer Main Business Overview
13.17.5 Pfizer Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Vaccination Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Human Vaccination by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Human Vaccination by Country/Region, 2018, 2022 & 2029
2.2 Human Vaccination Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Live-attenuated Vaccine
2.2.3 mRNA Vaccine
2.2.4 Conjugate Vaccine
2.2.5 Other
2.3 Human Vaccination Sales by Type
2.3.1 Global Human Vaccination Sales Market Share by Type (2018-2023)
2.3.2 Global Human Vaccination Revenue and Market Share by Type (2018-2023)
2.3.3 Global Human Vaccination Sale Price by Type (2018-2023)
2.4 Human Vaccination Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.4.3 Other
2.5 Human Vaccination Sales by Application
2.5.1 Global Human Vaccination Sale Market Share by Application (2018-2023)
2.5.2 Global Human Vaccination Revenue and Market Share by Application (2018-2023)
2.5.3 Global Human Vaccination Sale Price by Application (2018-2023)
3 GLOBAL HUMAN VACCINATION BY COMPANY
3.1 Global Human Vaccination Breakdown Data by Company
3.1.1 Global Human Vaccination Annual Sales by Company (2018-2023)
3.1.2 Global Human Vaccination Sales Market Share by Company (2018-2023)
3.2 Global Human Vaccination Annual Revenue by Company (2018-2023)
3.2.1 Global Human Vaccination Revenue by Company (2018-2023)
3.2.2 Global Human Vaccination Revenue Market Share by Company (2018-2023)
3.3 Global Human Vaccination Sale Price by Company
3.4 Key Manufacturers Human Vaccination Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Vaccination Product Location Distribution
3.4.2 Players Human Vaccination Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HUMAN VACCINATION BY GEOGRAPHIC REGION
4.1 World Historic Human Vaccination Market Size by Geographic Region (2018-2023)
4.1.1 Global Human Vaccination Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Human Vaccination Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Human Vaccination Market Size by Country/Region (2018-2023)
4.2.1 Global Human Vaccination Annual Sales by Country/Region (2018-2023)
4.2.2 Global Human Vaccination Annual Revenue by Country/Region (2018-2023)
4.3 Americas Human Vaccination Sales Growth
4.4 APAC Human Vaccination Sales Growth
4.5 Europe Human Vaccination Sales Growth
4.6 Middle East & Africa Human Vaccination Sales Growth
5 AMERICAS
5.1 Americas Human Vaccination Sales by Country
5.1.1 Americas Human Vaccination Sales by Country (2018-2023)
5.1.2 Americas Human Vaccination Revenue by Country (2018-2023)
5.2 Americas Human Vaccination Sales by Type
5.3 Americas Human Vaccination Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Vaccination Sales by Region
6.1.1 APAC Human Vaccination Sales by Region (2018-2023)
6.1.2 APAC Human Vaccination Revenue by Region (2018-2023)
6.2 APAC Human Vaccination Sales by Type
6.3 APAC Human Vaccination Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Vaccination by Country
7.1.1 Europe Human Vaccination Sales by Country (2018-2023)
7.1.2 Europe Human Vaccination Revenue by Country (2018-2023)
7.2 Europe Human Vaccination Sales by Type
7.3 Europe Human Vaccination Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Vaccination by Country
8.1.1 Middle East & Africa Human Vaccination Sales by Country (2018-2023)
8.1.2 Middle East & Africa Human Vaccination Revenue by Country (2018-2023)
8.2 Middle East & Africa Human Vaccination Sales by Type
8.3 Middle East & Africa Human Vaccination Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Vaccination
10.3 Manufacturing Process Analysis of Human Vaccination
10.4 Industry Chain Structure of Human Vaccination
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Vaccination Distributors
11.3 Human Vaccination Customer
12 WORLD FORECAST REVIEW FOR HUMAN VACCINATION BY GEOGRAPHIC REGION
12.1 Global Human Vaccination Market Size Forecast by Region
12.1.1 Global Human Vaccination Forecast by Region (2024-2029)
12.1.2 Global Human Vaccination Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Vaccination Forecast by Type
12.7 Global Human Vaccination Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Human Vaccination Product Portfolios and Specifications
13.1.3 GSK Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Human Vaccination Product Portfolios and Specifications
13.2.3 Merck Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Human Vaccination Product Portfolios and Specifications
13.3.3 Sanofi Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Sinovac
13.4.1 Sinovac Company Information
13.4.2 Sinovac Human Vaccination Product Portfolios and Specifications
13.4.3 Sinovac Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sinovac Main Business Overview
13.4.5 Sinovac Latest Developments
13.5 Zhejiang Pukang
13.5.1 Zhejiang Pukang Company Information
13.5.2 Zhejiang Pukang Human Vaccination Product Portfolios and Specifications
13.5.3 Zhejiang Pukang Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Zhejiang Pukang Main Business Overview
13.5.5 Zhejiang Pukang Latest Developments
13.6 Changchun Institute of Biological
13.6.1 Changchun Institute of Biological Company Information
13.6.2 Changchun Institute of Biological Human Vaccination Product Portfolios and Specifications
13.6.3 Changchun Institute of Biological Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Changchun Institute of Biological Main Business Overview
13.6.5 Changchun Institute of Biological Latest Developments
13.7 KM Biologics
13.7.1 KM Biologics Company Information
13.7.2 KM Biologics Human Vaccination Product Portfolios and Specifications
13.7.3 KM Biologics Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 KM Biologics Main Business Overview
13.7.5 KM Biologics Latest Developments
13.8 IMBCAMS
13.8.1 IMBCAMS Company Information
13.8.2 IMBCAMS Human Vaccination Product Portfolios and Specifications
13.8.3 IMBCAMS Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 IMBCAMS Main Business Overview
13.8.5 IMBCAMS Latest Developments
13.9 Convac
13.9.1 Convac Company Information
13.9.2 Convac Human Vaccination Product Portfolios and Specifications
13.9.3 Convac Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Convac Main Business Overview
13.9.5 Convac Latest Developments
13.10 NCPC
13.10.1 NCPC Company Information
13.10.2 NCPC Human Vaccination Product Portfolios and Specifications
13.10.3 NCPC Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 NCPC Main Business Overview
13.10.5 NCPC Latest Developments
13.11 Bio Kangtai
13.11.1 Bio Kangtai Company Information
13.11.2 Bio Kangtai Human Vaccination Product Portfolios and Specifications
13.11.3 Bio Kangtai Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Bio Kangtai Main Business Overview
13.11.5 Bio Kangtai Latest Developments
13.12 Dynavax
13.12.1 Dynavax Company Information
13.12.2 Dynavax Human Vaccination Product Portfolios and Specifications
13.12.3 Dynavax Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Dynavax Main Business Overview
13.12.5 Dynavax Latest Developments
13.13 Hissen
13.13.1 Hissen Company Information
13.13.2 Hissen Human Vaccination Product Portfolios and Specifications
13.13.3 Hissen Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Hissen Main Business Overview
13.13.5 Hissen Latest Developments
13.14 KM Biologics
13.14.1 KM Biologics Company Information
13.14.2 KM Biologics Human Vaccination Product Portfolios and Specifications
13.14.3 KM Biologics Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 KM Biologics Main Business Overview
13.14.5 KM Biologics Latest Developments
13.15 LG Life Sciences
13.15.1 LG Life Sciences Company Information
13.15.2 LG Life Sciences Human Vaccination Product Portfolios and Specifications
13.15.3 LG Life Sciences Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 LG Life Sciences Main Business Overview
13.15.5 LG Life Sciences Latest Developments
13.16 Serum Institute
13.16.1 Serum Institute Company Information
13.16.2 Serum Institute Human Vaccination Product Portfolios and Specifications
13.16.3 Serum Institute Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Serum Institute Main Business Overview
13.16.5 Serum Institute Latest Developments
13.17 Pfizer
13.17.1 Pfizer Company Information
13.17.2 Pfizer Human Vaccination Product Portfolios and Specifications
13.17.3 Pfizer Human Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Pfizer Main Business Overview
13.17.5 Pfizer Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Vaccination Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Human Vaccination Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Inactivated Vaccine
Table 4. Major Players of Live-attenuated Vaccine
Table 5. Major Players of mRNA Vaccine
Table 6. Major Players of Conjugate Vaccine
Table 7. Major Players of Other
Table 8. Global Human Vaccination Sales by Type (2018-2023) & (Units)
Table 9. Global Human Vaccination Sales Market Share by Type (2018-2023)
Table 10. Global Human Vaccination Revenue by Type (2018-2023) & ($ million)
Table 11. Global Human Vaccination Revenue Market Share by Type (2018-2023)
Table 12. Global Human Vaccination Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Human Vaccination Sales by Application (2018-2023) & (Units)
Table 14. Global Human Vaccination Sales Market Share by Application (2018-2023)
Table 15. Global Human Vaccination Revenue by Application (2018-2023)
Table 16. Global Human Vaccination Revenue Market Share by Application (2018-2023)
Table 17. Global Human Vaccination Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Human Vaccination Sales by Company (2018-2023) & (Units)
Table 19. Global Human Vaccination Sales Market Share by Company (2018-2023)
Table 20. Global Human Vaccination Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Human Vaccination Revenue Market Share by Company (2018-2023)
Table 22. Global Human Vaccination Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Human Vaccination Producing Area Distribution and Sales Area
Table 24. Players Human Vaccination Products Offered
Table 25. Human Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Human Vaccination Sales by Geographic Region (2018-2023) & (Units)
Table 29. Global Human Vaccination Sales Market Share Geographic Region (2018-2023)
Table 30. Global Human Vaccination Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Human Vaccination Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Human Vaccination Sales by Country/Region (2018-2023) & (Units)
Table 33. Global Human Vaccination Sales Market Share by Country/Region (2018-2023)
Table 34. Global Human Vaccination Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Human Vaccination Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Human Vaccination Sales by Country (2018-2023) & (Units)
Table 37. Americas Human Vaccination Sales Market Share by Country (2018-2023)
Table 38. Americas Human Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Human Vaccination Revenue Market Share by Country (2018-2023)
Table 40. Americas Human Vaccination Sales by Type (2018-2023) & (Units)
Table 41. Americas Human Vaccination Sales by Application (2018-2023) & (Units)
Table 42. APAC Human Vaccination Sales by Region (2018-2023) & (Units)
Table 43. APAC Human Vaccination Sales Market Share by Region (2018-2023)
Table 44. APAC Human Vaccination Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Human Vaccination Revenue Market Share by Region (2018-2023)
Table 46. APAC Human Vaccination Sales by Type (2018-2023) & (Units)
Table 47. APAC Human Vaccination Sales by Application (2018-2023) & (Units)
Table 48. Europe Human Vaccination Sales by Country (2018-2023) & (Units)
Table 49. Europe Human Vaccination Sales Market Share by Country (2018-2023)
Table 50. Europe Human Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Human Vaccination Revenue Market Share by Country (2018-2023)
Table 52. Europe Human Vaccination Sales by Type (2018-2023) & (Units)
Table 53. Europe Human Vaccination Sales by Application (2018-2023) & (Units)
Table 54. Middle East & Africa Human Vaccination Sales by Country (2018-2023) & (Units)
Table 55. Middle East & Africa Human Vaccination Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Human Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Human Vaccination Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Human Vaccination Sales by Type (2018-2023) & (Units)
Table 59. Middle East & Africa Human Vaccination Sales by Application (2018-2023) & (Units)
Table 60. Key Market Drivers & Growth Opportunities of Human Vaccination
Table 61. Key Market Challenges & Risks of Human Vaccination
Table 62. Key Industry Trends of Human Vaccination
Table 63. Human Vaccination Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Human Vaccination Distributors List
Table 66. Human Vaccination Customer List
Table 67. Global Human Vaccination Sales Forecast by Region (2024-2029) & (Units)
Table 68. Global Human Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Human Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 70. Americas Human Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Human Vaccination Sales Forecast by Region (2024-2029) & (Units)
Table 72. APAC Human Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Human Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 74. Europe Human Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Human Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 76. Middle East & Africa Human Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Human Vaccination Sales Forecast by Type (2024-2029) & (Units)
Table 78. Global Human Vaccination Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Human Vaccination Sales Forecast by Application (2024-2029) & (Units)
Table 80. Global Human Vaccination Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. GSK Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 82. GSK Human Vaccination Product Portfolios and Specifications
Table 83. GSK Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. GSK Main Business
Table 85. GSK Latest Developments
Table 86. Merck Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 87. Merck Human Vaccination Product Portfolios and Specifications
Table 88. Merck Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Merck Main Business
Table 90. Merck Latest Developments
Table 91. Sanofi Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 92. Sanofi Human Vaccination Product Portfolios and Specifications
Table 93. Sanofi Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Sanofi Main Business
Table 95. Sanofi Latest Developments
Table 96. Sinovac Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 97. Sinovac Human Vaccination Product Portfolios and Specifications
Table 98. Sinovac Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Sinovac Main Business
Table 100. Sinovac Latest Developments
Table 101. Zhejiang Pukang Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 102. Zhejiang Pukang Human Vaccination Product Portfolios and Specifications
Table 103. Zhejiang Pukang Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Zhejiang Pukang Main Business
Table 105. Zhejiang Pukang Latest Developments
Table 106. Changchun Institute of Biological Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 107. Changchun Institute of Biological Human Vaccination Product Portfolios and Specifications
Table 108. Changchun Institute of Biological Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Changchun Institute of Biological Main Business
Table 110. Changchun Institute of Biological Latest Developments
Table 111. KM Biologics Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 112. KM Biologics Human Vaccination Product Portfolios and Specifications
Table 113. KM Biologics Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. KM Biologics Main Business
Table 115. KM Biologics Latest Developments
Table 116. IMBCAMS Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 117. IMBCAMS Human Vaccination Product Portfolios and Specifications
Table 118. IMBCAMS Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. IMBCAMS Main Business
Table 120. IMBCAMS Latest Developments
Table 121. Convac Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 122. Convac Human Vaccination Product Portfolios and Specifications
Table 123. Convac Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Convac Main Business
Table 125. Convac Latest Developments
Table 126. NCPC Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 127. NCPC Human Vaccination Product Portfolios and Specifications
Table 128. NCPC Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. NCPC Main Business
Table 130. NCPC Latest Developments
Table 131. Bio Kangtai Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 132. Bio Kangtai Human Vaccination Product Portfolios and Specifications
Table 133. Bio Kangtai Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Bio Kangtai Main Business
Table 135. Bio Kangtai Latest Developments
Table 136. Dynavax Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 137. Dynavax Human Vaccination Product Portfolios and Specifications
Table 138. Dynavax Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. Dynavax Main Business
Table 140. Dynavax Latest Developments
Table 141. Hissen Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 142. Hissen Human Vaccination Product Portfolios and Specifications
Table 143. Hissen Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 144. Hissen Main Business
Table 145. Hissen Latest Developments
Table 146. KM Biologics Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 147. KM Biologics Human Vaccination Product Portfolios and Specifications
Table 148. KM Biologics Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 149. KM Biologics Main Business
Table 150. KM Biologics Latest Developments
Table 151. LG Life Sciences Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 152. LG Life Sciences Human Vaccination Product Portfolios and Specifications
Table 153. LG Life Sciences Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 154. LG Life Sciences Main Business
Table 155. LG Life Sciences Latest Developments
Table 156. Serum Institute Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 157. Serum Institute Human Vaccination Product Portfolios and Specifications
Table 158. Serum Institute Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 159. Serum Institute Main Business
Table 160. Serum Institute Latest Developments
Table 161. Pfizer Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 162. Pfizer Human Vaccination Product Portfolios and Specifications
Table 163. Pfizer Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 164. Pfizer Main Business
Table 165. Pfizer Latest Developments
Table 1. Human Vaccination Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Human Vaccination Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Inactivated Vaccine
Table 4. Major Players of Live-attenuated Vaccine
Table 5. Major Players of mRNA Vaccine
Table 6. Major Players of Conjugate Vaccine
Table 7. Major Players of Other
Table 8. Global Human Vaccination Sales by Type (2018-2023) & (Units)
Table 9. Global Human Vaccination Sales Market Share by Type (2018-2023)
Table 10. Global Human Vaccination Revenue by Type (2018-2023) & ($ million)
Table 11. Global Human Vaccination Revenue Market Share by Type (2018-2023)
Table 12. Global Human Vaccination Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Human Vaccination Sales by Application (2018-2023) & (Units)
Table 14. Global Human Vaccination Sales Market Share by Application (2018-2023)
Table 15. Global Human Vaccination Revenue by Application (2018-2023)
Table 16. Global Human Vaccination Revenue Market Share by Application (2018-2023)
Table 17. Global Human Vaccination Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Human Vaccination Sales by Company (2018-2023) & (Units)
Table 19. Global Human Vaccination Sales Market Share by Company (2018-2023)
Table 20. Global Human Vaccination Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Human Vaccination Revenue Market Share by Company (2018-2023)
Table 22. Global Human Vaccination Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Human Vaccination Producing Area Distribution and Sales Area
Table 24. Players Human Vaccination Products Offered
Table 25. Human Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Human Vaccination Sales by Geographic Region (2018-2023) & (Units)
Table 29. Global Human Vaccination Sales Market Share Geographic Region (2018-2023)
Table 30. Global Human Vaccination Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Human Vaccination Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Human Vaccination Sales by Country/Region (2018-2023) & (Units)
Table 33. Global Human Vaccination Sales Market Share by Country/Region (2018-2023)
Table 34. Global Human Vaccination Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Human Vaccination Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Human Vaccination Sales by Country (2018-2023) & (Units)
Table 37. Americas Human Vaccination Sales Market Share by Country (2018-2023)
Table 38. Americas Human Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Human Vaccination Revenue Market Share by Country (2018-2023)
Table 40. Americas Human Vaccination Sales by Type (2018-2023) & (Units)
Table 41. Americas Human Vaccination Sales by Application (2018-2023) & (Units)
Table 42. APAC Human Vaccination Sales by Region (2018-2023) & (Units)
Table 43. APAC Human Vaccination Sales Market Share by Region (2018-2023)
Table 44. APAC Human Vaccination Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Human Vaccination Revenue Market Share by Region (2018-2023)
Table 46. APAC Human Vaccination Sales by Type (2018-2023) & (Units)
Table 47. APAC Human Vaccination Sales by Application (2018-2023) & (Units)
Table 48. Europe Human Vaccination Sales by Country (2018-2023) & (Units)
Table 49. Europe Human Vaccination Sales Market Share by Country (2018-2023)
Table 50. Europe Human Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Human Vaccination Revenue Market Share by Country (2018-2023)
Table 52. Europe Human Vaccination Sales by Type (2018-2023) & (Units)
Table 53. Europe Human Vaccination Sales by Application (2018-2023) & (Units)
Table 54. Middle East & Africa Human Vaccination Sales by Country (2018-2023) & (Units)
Table 55. Middle East & Africa Human Vaccination Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Human Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Human Vaccination Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Human Vaccination Sales by Type (2018-2023) & (Units)
Table 59. Middle East & Africa Human Vaccination Sales by Application (2018-2023) & (Units)
Table 60. Key Market Drivers & Growth Opportunities of Human Vaccination
Table 61. Key Market Challenges & Risks of Human Vaccination
Table 62. Key Industry Trends of Human Vaccination
Table 63. Human Vaccination Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Human Vaccination Distributors List
Table 66. Human Vaccination Customer List
Table 67. Global Human Vaccination Sales Forecast by Region (2024-2029) & (Units)
Table 68. Global Human Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Human Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 70. Americas Human Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Human Vaccination Sales Forecast by Region (2024-2029) & (Units)
Table 72. APAC Human Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Human Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 74. Europe Human Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Human Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 76. Middle East & Africa Human Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Human Vaccination Sales Forecast by Type (2024-2029) & (Units)
Table 78. Global Human Vaccination Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Human Vaccination Sales Forecast by Application (2024-2029) & (Units)
Table 80. Global Human Vaccination Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. GSK Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 82. GSK Human Vaccination Product Portfolios and Specifications
Table 83. GSK Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. GSK Main Business
Table 85. GSK Latest Developments
Table 86. Merck Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 87. Merck Human Vaccination Product Portfolios and Specifications
Table 88. Merck Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Merck Main Business
Table 90. Merck Latest Developments
Table 91. Sanofi Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 92. Sanofi Human Vaccination Product Portfolios and Specifications
Table 93. Sanofi Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Sanofi Main Business
Table 95. Sanofi Latest Developments
Table 96. Sinovac Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 97. Sinovac Human Vaccination Product Portfolios and Specifications
Table 98. Sinovac Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Sinovac Main Business
Table 100. Sinovac Latest Developments
Table 101. Zhejiang Pukang Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 102. Zhejiang Pukang Human Vaccination Product Portfolios and Specifications
Table 103. Zhejiang Pukang Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Zhejiang Pukang Main Business
Table 105. Zhejiang Pukang Latest Developments
Table 106. Changchun Institute of Biological Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 107. Changchun Institute of Biological Human Vaccination Product Portfolios and Specifications
Table 108. Changchun Institute of Biological Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Changchun Institute of Biological Main Business
Table 110. Changchun Institute of Biological Latest Developments
Table 111. KM Biologics Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 112. KM Biologics Human Vaccination Product Portfolios and Specifications
Table 113. KM Biologics Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. KM Biologics Main Business
Table 115. KM Biologics Latest Developments
Table 116. IMBCAMS Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 117. IMBCAMS Human Vaccination Product Portfolios and Specifications
Table 118. IMBCAMS Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. IMBCAMS Main Business
Table 120. IMBCAMS Latest Developments
Table 121. Convac Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 122. Convac Human Vaccination Product Portfolios and Specifications
Table 123. Convac Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Convac Main Business
Table 125. Convac Latest Developments
Table 126. NCPC Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 127. NCPC Human Vaccination Product Portfolios and Specifications
Table 128. NCPC Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. NCPC Main Business
Table 130. NCPC Latest Developments
Table 131. Bio Kangtai Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 132. Bio Kangtai Human Vaccination Product Portfolios and Specifications
Table 133. Bio Kangtai Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Bio Kangtai Main Business
Table 135. Bio Kangtai Latest Developments
Table 136. Dynavax Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 137. Dynavax Human Vaccination Product Portfolios and Specifications
Table 138. Dynavax Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. Dynavax Main Business
Table 140. Dynavax Latest Developments
Table 141. Hissen Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 142. Hissen Human Vaccination Product Portfolios and Specifications
Table 143. Hissen Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 144. Hissen Main Business
Table 145. Hissen Latest Developments
Table 146. KM Biologics Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 147. KM Biologics Human Vaccination Product Portfolios and Specifications
Table 148. KM Biologics Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 149. KM Biologics Main Business
Table 150. KM Biologics Latest Developments
Table 151. LG Life Sciences Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 152. LG Life Sciences Human Vaccination Product Portfolios and Specifications
Table 153. LG Life Sciences Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 154. LG Life Sciences Main Business
Table 155. LG Life Sciences Latest Developments
Table 156. Serum Institute Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 157. Serum Institute Human Vaccination Product Portfolios and Specifications
Table 158. Serum Institute Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 159. Serum Institute Main Business
Table 160. Serum Institute Latest Developments
Table 161. Pfizer Basic Information, Human Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 162. Pfizer Human Vaccination Product Portfolios and Specifications
Table 163. Pfizer Human Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 164. Pfizer Main Business
Table 165. Pfizer Latest Developments
LIST OF FIGURES
Figure 1. Picture of Human Vaccination
Figure 2. Human Vaccination Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Vaccination Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Human Vaccination Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Human Vaccination Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Inactivated Vaccine
Figure 10. Product Picture of Live-attenuated Vaccine
Figure 11. Product Picture of mRNA Vaccine
Figure 12. Product Picture of Conjugate Vaccine
Figure 13. Product Picture of Other
Figure 14. Global Human Vaccination Sales Market Share by Type in 2022
Figure 15. Global Human Vaccination Revenue Market Share by Type (2018-2023)
Figure 16. Human Vaccination Consumed in Government Institution
Figure 17. Global Human Vaccination Market: Government Institution (2018-2023) & (Units)
Figure 18. Human Vaccination Consumed in Private Sector
Figure 19. Global Human Vaccination Market: Private Sector (2018-2023) & (Units)
Figure 20. Human Vaccination Consumed in Other
Figure 21. Global Human Vaccination Market: Other (2018-2023) & (Units)
Figure 22. Global Human Vaccination Sales Market Share by Application (2022)
Figure 23. Global Human Vaccination Revenue Market Share by Application in 2022
Figure 24. Human Vaccination Sales Market by Company in 2022 (Units)
Figure 25. Global Human Vaccination Sales Market Share by Company in 2022
Figure 26. Human Vaccination Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Human Vaccination Revenue Market Share by Company in 2022
Figure 28. Global Human Vaccination Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Human Vaccination Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Human Vaccination Sales 2018-2023 (Units)
Figure 31. Americas Human Vaccination Revenue 2018-2023 ($ Millions)
Figure 32. APAC Human Vaccination Sales 2018-2023 (Units)
Figure 33. APAC Human Vaccination Revenue 2018-2023 ($ Millions)
Figure 34. Europe Human Vaccination Sales 2018-2023 (Units)
Figure 35. Europe Human Vaccination Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Human Vaccination Sales 2018-2023 (Units)
Figure 37. Middle East & Africa Human Vaccination Revenue 2018-2023 ($ Millions)
Figure 38. Americas Human Vaccination Sales Market Share by Country in 2022
Figure 39. Americas Human Vaccination Revenue Market Share by Country in 2022
Figure 40. Americas Human Vaccination Sales Market Share by Type (2018-2023)
Figure 41. Americas Human Vaccination Sales Market Share by Application (2018-2023)
Figure 42. United States Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Human Vaccination Sales Market Share by Region in 2022
Figure 47. APAC Human Vaccination Revenue Market Share by Regions in 2022
Figure 48. APAC Human Vaccination Sales Market Share by Type (2018-2023)
Figure 49. APAC Human Vaccination Sales Market Share by Application (2018-2023)
Figure 50. China Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Human Vaccination Sales Market Share by Country in 2022
Figure 58. Europe Human Vaccination Revenue Market Share by Country in 2022
Figure 59. Europe Human Vaccination Sales Market Share by Type (2018-2023)
Figure 60. Europe Human Vaccination Sales Market Share by Application (2018-2023)
Figure 61. Germany Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Human Vaccination Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Human Vaccination Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Human Vaccination Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Human Vaccination Sales Market Share by Application (2018-2023)
Figure 70. Egypt Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Human Vaccination in 2022
Figure 76. Manufacturing Process Analysis of Human Vaccination
Figure 77. Industry Chain Structure of Human Vaccination
Figure 78. Channels of Distribution
Figure 79. Global Human Vaccination Sales Market Forecast by Region (2024-2029)
Figure 80. Global Human Vaccination Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Human Vaccination Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Human Vaccination Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Human Vaccination Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Human Vaccination Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Human Vaccination
Figure 2. Human Vaccination Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Vaccination Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Human Vaccination Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Human Vaccination Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Inactivated Vaccine
Figure 10. Product Picture of Live-attenuated Vaccine
Figure 11. Product Picture of mRNA Vaccine
Figure 12. Product Picture of Conjugate Vaccine
Figure 13. Product Picture of Other
Figure 14. Global Human Vaccination Sales Market Share by Type in 2022
Figure 15. Global Human Vaccination Revenue Market Share by Type (2018-2023)
Figure 16. Human Vaccination Consumed in Government Institution
Figure 17. Global Human Vaccination Market: Government Institution (2018-2023) & (Units)
Figure 18. Human Vaccination Consumed in Private Sector
Figure 19. Global Human Vaccination Market: Private Sector (2018-2023) & (Units)
Figure 20. Human Vaccination Consumed in Other
Figure 21. Global Human Vaccination Market: Other (2018-2023) & (Units)
Figure 22. Global Human Vaccination Sales Market Share by Application (2022)
Figure 23. Global Human Vaccination Revenue Market Share by Application in 2022
Figure 24. Human Vaccination Sales Market by Company in 2022 (Units)
Figure 25. Global Human Vaccination Sales Market Share by Company in 2022
Figure 26. Human Vaccination Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Human Vaccination Revenue Market Share by Company in 2022
Figure 28. Global Human Vaccination Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Human Vaccination Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Human Vaccination Sales 2018-2023 (Units)
Figure 31. Americas Human Vaccination Revenue 2018-2023 ($ Millions)
Figure 32. APAC Human Vaccination Sales 2018-2023 (Units)
Figure 33. APAC Human Vaccination Revenue 2018-2023 ($ Millions)
Figure 34. Europe Human Vaccination Sales 2018-2023 (Units)
Figure 35. Europe Human Vaccination Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Human Vaccination Sales 2018-2023 (Units)
Figure 37. Middle East & Africa Human Vaccination Revenue 2018-2023 ($ Millions)
Figure 38. Americas Human Vaccination Sales Market Share by Country in 2022
Figure 39. Americas Human Vaccination Revenue Market Share by Country in 2022
Figure 40. Americas Human Vaccination Sales Market Share by Type (2018-2023)
Figure 41. Americas Human Vaccination Sales Market Share by Application (2018-2023)
Figure 42. United States Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Human Vaccination Sales Market Share by Region in 2022
Figure 47. APAC Human Vaccination Revenue Market Share by Regions in 2022
Figure 48. APAC Human Vaccination Sales Market Share by Type (2018-2023)
Figure 49. APAC Human Vaccination Sales Market Share by Application (2018-2023)
Figure 50. China Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Human Vaccination Sales Market Share by Country in 2022
Figure 58. Europe Human Vaccination Revenue Market Share by Country in 2022
Figure 59. Europe Human Vaccination Sales Market Share by Type (2018-2023)
Figure 60. Europe Human Vaccination Sales Market Share by Application (2018-2023)
Figure 61. Germany Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Human Vaccination Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Human Vaccination Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Human Vaccination Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Human Vaccination Sales Market Share by Application (2018-2023)
Figure 70. Egypt Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Human Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Human Vaccination in 2022
Figure 76. Manufacturing Process Analysis of Human Vaccination
Figure 77. Industry Chain Structure of Human Vaccination
Figure 78. Channels of Distribution
Figure 79. Global Human Vaccination Sales Market Forecast by Region (2024-2029)
Figure 80. Global Human Vaccination Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Human Vaccination Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Human Vaccination Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Human Vaccination Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Human Vaccination Revenue Market Share Forecast by Application (2024-2029)
